Identification of Bladder Cancer Patients at Risk for Recurrence or Progression: An Immunohistochemical Study Based on the Expression of Metallothionein

REFERENCES

• Bahnson , R. R. , Banner , B. F. , Ernstoff , M. S. , Lazo , J. S. , Cherian , M. G. , Banerjee , D. and Chin , J. L. 1991 . Immunohistochemical localization of metallothionein in transitional cell carcinoma of the bladder . J. Urol. , 146 : 1518 – 1520 .
   PubMed Web of Science ®Google Scholar
• Bahnson , R. R. , Becich , M. , Ernstoff , M. S. , Sandlow , J. , Cohen , M. B. and Williams , R. D. 1994 . Absence of immunohistochemical metallothionein staining in bladder tumor specimens predicts response to neoadjuvant cisplatin, methotrexate and vinblastine chemotherapy . J. Urol. , 152 : 2272 – 2275 .
   PubMed Web of Science ®Google Scholar
• Cherian , M. G. , Jayasurya , A. and Bay , B. H. 2003 . Metallothioneins in human tumors and potential roles in carcinogenesis . Mutat. Res. , 533 : 201 – 209 .
   PubMed Web of Science ®Google Scholar
• Detre , S. , Saclani Jotti , G. and Dowsett , M. 1995 . A “quickscore” method for immunohistochemical semiquantitation: Validation for oestrogen receptor in breast carcinomas . J. Clin. Pathol. , 48 : 876 – 878 .
   PubMed Web of Science ®Google Scholar
• de Vere White , R. W. and Stapp , E. 1998 . Predicting prognosis in patients with superficial bladder cancer . Oncology (Huntingt.) , 12 : 1717 – 1726 .
   Google Scholar
• Duncan , E. L. and Reddel , R. R. 1999 . Downregulation of metallothionein-IIA expression occurs at immortalization . Oncogene , 18 : 897 – 903 .
   PubMed Web of Science ®Google Scholar
• Esrig , D. , Elmajian , D. , Groshen , S. , Freeman , J. A. , Stein , J. P. , Chen , S. C. , Nichols , P. W. , Skinner , D. G. , Jones , P. A. and Cote , R. J. 1994 . Accumulation of nuclear p53 and tumor progression in bladder cancer . N. Engl. J. Med. , 331 : 1259 – 1264 .
   PubMed Web of Science ®Google Scholar
• Fukuzawa , S. , Hashimura , T. , Sasaki , M. , Yamabe , H. and Yoshida , O. 1995 . Nuclear morphometry for improved prediction of the prognosis of human bladder carcinoma . Cancer , 76 : 1790 – 1796 .
   Google Scholar
• Haerslev , T. , Jacobsen , G. K. and Zedeler , K. 1995 . The prognostic significance of immunohistochemically detectable metallothionein in primary breast carcinomas . APMIS , 103 : 279 – 285 .
   PubMedGoogle Scholar
• Hishikawa , Y. , Koji , T. , Dhar , D. K. , Kinugasa , S. , Yamaguchi , M. and Nagasue , N. 1999 . Metallothionein expression correlates with metastatic and proliferative potential in squamous cell carcinoma of the oesophagus . Br. J. Cancer. , 81 : 712 – 720 .
   Google Scholar
• Hiura , T. , Khalid , H. , Yamashita , H. , Tokunaga , Y. , Yasunaga , A. and Shibata , S. 1998 . Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival . Cancer , 83 : 2361 – 2369 .
   PubMed Web of Science ®Google Scholar
• Ioachim , E. E. , Charchant , i. A. V. , Stavropoulos , N. E. , Athanassiou , E. D. , Michael , M. C. and Agnantis , N. J. 2001 . Localization of metallothionein in urothelial carcinoma of the human urinary bladder: An immunohistochemical study including correlation with HLA-DR antigen, p53, and proliferation indices . Anticancer Res. , 21 : 1757 – 1761 .
   Google Scholar
• Joseph , M. G. , Banerjee , D. , Kocha , W. , Feld , R. , Stitt , L. W. and Cherian , M. G. 2001 . Metallothionein expression in patients with small cell carcinoma of the lung: correlation with other molecular markers and clinical outcome . Cancer , 92 : 836 – 842 .
   PubMed Web of Science ®Google Scholar
• Kotoh , S. , Naito , S. , Sakamoto , N. , Goto , K. and Kumazawa , J. 1994 . Metallothionein expression is correlated with cisplatin resistance in transitional cell carcinoma of the urinary tract . J. Urol. , 152 : 1267 – 1270 .
   Google Scholar
• Malkowicz , S. B. 1997 . Superficial bladder cancer: the role of molecular markers in the treatment of high-risk superficial disease . Semin. Urol. Oncol. , 15 : 169 – 178 .
   Google Scholar
• Manuel , Y. , Thomas , Y. and Pellegrini , O. 1992 . Metallothionein and tissue damage . IARC Sci. Publ. , 118 : 231 – 237 .
   Google Scholar
• Nagel , W. W. and Vallee , B. L. 1995 . Cell cycle regulation of metallothionein in human colonic cancer cells . Proc. Natl. Acad. Sci. USA , 92 : 579 – 583 .
   PubMed Web of Science ®Google Scholar
• Ofner , D. , Maier , H. , Riedmann , B. , Bammer , T. , Rumer , A. , Winde , G. , Bocker , W. , Jasani , B. and Schmid , K. W. 1994 . Immunohistochemical metallothionein expression in colorectal adenocarcinoma: Correlation with tumour stage and patient survival . Virchows Arch. , 425 : 491 – 497 .
   PubMedGoogle Scholar
• Ohshio , G. , Imamura , T. , Okada , N. , Wang , Z. H. , Yamaki , K. , Kyogoku , T. , Suwa , H. , Yamabe , H. and Imamura , M. 1996 . Immunohistochemical study of metallothionein in pancreatic carcinomas . J. Cancer Res. Clin. Oncol. , 122 : 351 – 355 .
   Google Scholar
• Oikawa , S. , Kurasaki , M. , Kojima , Y. and Kawanishi , S. 1995 . Oxidative and nonoxidative mechanisms of site-specific DNA cleavage induced by copper-containing metallothioneins . Biochemistry , 34 : 8763 – 8770 .
   PubMed Web of Science ®Google Scholar
• Ostrakhovitch , E. A. , Olsson , P. E. , Jiang , S. and Cherian , M. G. 2006 . Interaction of metallothionein with tumor suppressor p53 protein . FEBS Lett. , 580 : 1235 – 1238 .
   PubMed Web of Science ®Google Scholar
• Saga , Y. , Hashimoto , H. , Yachiku , S. , Tokumitsu , M. and Kaneko , S. 2002 . Immunohistochemical expression of metallothionein in human bladder cancer: Correlation with histopathological parameters and patient survival . J. Urol. , 168 : 2227 – 2231 .
   Google Scholar
• Saika , T. , Tsushima , T. , Ochi , J. , Akebi , N. , Nasu , Y. , Matsumura , Y. and Ohmori , H. 1994 . Over-expression of metallothionein and drug-resistance in bladder cancer . Int. J. Urol. , 1 : 135 – 139 .
   Google Scholar
• Sauter , G. , Gasser , T. C. , Moch , H. , Richter , J. , Jiang , F. , Albrecht , R. , Novotny , H. , Wagner , U. , Bubendorf , L. and Mihatsch , M. J. 1997 . DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH . Urol. Res. , 25 ( Suppl 1 ) : 37 – 43 .
   Google Scholar
• Schmid , K. W. , Zelger , B. , Hittmair , A. , Laidler , P. , Jasani , B. and Böcker , W. 1992 . Metallothionein-Überexpression in malignen Melanomen. Zusammenhang mit Prognose und Therapie . Verh. Dtsch. Ges. Pathol. , 76 : 512 – 516 .
   Google Scholar
• Schroeder , J. J. and Cousins , R. J. 1990 . Interleukin-6 regulates metallothionein gene expression and zinc metabolism in hepatocyte monolayer cell cultures . Proc. Natl. Acad. Sci. USA , 87 : 3137 – 3141 .
   PubMed Web of Science ®Google Scholar
• Sens , M. A. , Somji , S. , Lamm , D. L. , Garrett , S. H. , Slovinsky , F. , Todd , J. H. and Sens , D. A. 2000 . Metallothionein isoform 3 as a potential biomarker for human bladder cancer . Environ. Health Perspect. , 108 : 413 – 418 .
   Google Scholar
• Siu , L. L. , Banerjee , D. , Khurana , R. J. , Pan , X. , Pflueger , R. , Tannock , I. F. and Moore , M. J. 1998 . The prognostic role of p53, metallothionein, P-glycoprotein, and MIB-1 in muscle-invasive urothelial transitional cell carcinoma . Clin. Cancer Res. , 4 : 559 – 565 .
   PubMed Web of Science ®Google Scholar
• Sobin , L. H. , Wittekin , C. H. and International Union Against Cancer . 1997 . TNM classification of malignant tumors , 5th , New York : Wiley .
   Google Scholar
• Stein , J. P. , Ginsberg , D. A. , Grossfeld , G. D. , Chatterjee , S. J. , Esrig , D. , Dickinson , M. G. , Groshen , S. , Taylor , C. R. , Jones , P. A. , Skinner , D. G. and Cote , R. J. 1998 . Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer . J. Natl. Cancer Inst. , 15 : 1072 – 1079 .
   Google Scholar
• Tohyama , C. , Suzuki , J. S. , Homma , S. , Karasawa , M. , Kuroki , T. , Nishimura , H. and Nishimura , N. 1996 . Testosterone-dependent induction of metallothionein in genital organs of male rats . Biochem. J. , 317 : 97 – 102 .
   PubMed Web of Science ®Google Scholar
• Tuzel , E. , Kirkali , Z. , Yorukoglu , K. , Mungan , M. U. and Sade , M. 2001 . Metallothionein expression in renal cell carcinoma: subcellular localization and prognostic significance . J. Urol. , 165 : 1710 – 1713 .
   PubMed Web of Science ®Google Scholar
• Waalkes , M. P. , Donovan , M. P. and Thomas , J. A. 1982 . Cadmium-induced prostate metallothionein in the rabbit . Prostate , 3 : 23 – 25 .
   Google Scholar
• Waalkes , M. P. and Goering , P. L. 1990 . Metallothionein and other cadmium binding proteins: recent developments . Chem. Res. Toxicol. , 3 : 281 – 288 .
   PubMed Web of Science ®Google Scholar
• Woo , E. S. , Kondo , Y. , Watkins , S. C. , Hoyt , D. G. and Lazo , J. S. 1996 . Nucleophilic distribution of metallothionein in human tumor cells . Exp. Cell Res. , 224 : 365 – 371 .
   PubMedGoogle Scholar
• Yamasaki , Y. , Smith , C. , Weisz , D. , van Huizen , I. , Xuan , J. , Moussa , M. , Stitt , L. , Hideki , S. , Cherian , M. G. and Izawa , J. I. 2006 . Metallothionein expression as prognostic factor for transitional cell carcinoma of bladder . Urology , 67 : 530 – 535 .
   Google Scholar
• Zhou , X. D. , Sens , D. A. , Sens , M. A. , Namburi , V. B. , Singh , R. K. , Garrett , S. H. and Somji , S. 2006 . Metallothionein-1 and -2 expression in cadmium- or arsenic-derived human malignant urothelial cells and tumor heterotransplants and as a prognostic indicator in human bladder cancer . Toxicol. Sci. , 91 : 467 – 475 .
   Google Scholar
• Zlotta , A. R. , Noel , J. C. , Fayt , I. , Drowart , A. , Van Vooren , J. P. , Huygen , K. , Simon , J. and Schulman , C. C. 1999 . Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette–Guerin intravesical therapy . J. Urol. , 161 : 792 – 798 .
   PubMed Web of Science ®Google Scholar